MedTrace Logo

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

NCT04407143 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1980

Last updated 2026-02-09

No results posted yet for this study

Summary

Observational, retrospective data collection and prospective IgG analysis, and multicenter study.

The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection.

For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.

Conditions

Interventions

DIAGNOSTIC_TEST

IgG test

IgG+ blood test by ELISA method.

Sponsors & Collaborators

  • Fundación GECP

    lead OTHER

Principal Investigators

  • Mariano Provencio, MD · Hospital Puerta de Hierro de Majadahonda de Madrid

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2022-04-30
Completion
2022-05-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407143 on ClinicalTrials.gov